Human albumin enriched St. Thomas Hospital cardioplegic solution increases reperfusion injury in isolated perfused rat hearts

Pharmacological Research

Volumn 37, Issue 2, 1998, Pages 97-101

  Süzer, Öner ^a   Köseoǧlu, Sabahat ^a   Özüner, Zeki ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Human albumin; Ischaemia reperfusion; Isolated rat heart; St. Thomas Hospital cardioplegic solution

Indexed keywords

CARDIOPLEGIC AGENT; CREATINE KINASE; HUMAN ALBUMIN; LACTATE DEHYDROGENASE; PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; FEMALE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART RATE; ISOLATED HEART; MALE; MORBIDITY; MORTALITY; NONHUMAN; OPEN HEART SURGERY; PRECIPITATION; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

EID: 0032005036     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.1997.0242     Document Type: Article

References (18)

1. 1. Fisher RB, Young DAB: Direct determination of extracellular fluid in the rat heart. J Physiol 1961; 158: 50.
2. 2. Döring HJ, Dehnert H. Perfusion Solutions. In: The isolated perfused heart according to Langendorff Biomesstechnik Verlag, March, 1988; pp. 31-3.
3. 3. Okado T. Effect of dextran on the stability of isolated perfused rat heart. Jpn J Physiol 1989; 39: 943-8.
4. 4. Kirklin JW, Barrat-Boyes BG. Myocardial protection during cardiac surgery with cardiopulmonary bypass. In: Cardiac Surgery. New York: John Wiley & Sons, 1986; pp. 83-108.
5. 5. Demmy TL, Haggerty SP, Boley TM, Curtis JJ. Lack of cardioplegia uniformity in clinical myocardial preservation. Ann Thorac Surg 1994; 57: 648-51.
6. 6. Zikria AB, Subbarao C, Oz M, Shih ST, McLeod PF, Sachdev R, Freeman HP, Hardy MA. Macromolecules reduce abnormal microvascular permeability in rat limb ischemia-reperfusion injury. Crit Care Med 1989; 17: 1306-9.
7. 7. Oz MC, Zikria BA, McLeod PF, Fitzpatrick MF, Duran WN, King CT. Hydroxyethyl starch macromolecules protect against increases in microvascular permeability following ischemia-reperfusion injury. American Coll Surgeons Surg Forum 1989; XL: 48-50.
8. 8. Zikria AB. Reduction of ischemia-reperfusion injury of myocardium by hydroxyethylstarch macromolecules: Circulation 1988; 78: II-80.
9. 9. Albes M, Baumgartel I, Rohde R, Hausen B, Demertzis S, Wahlers T. Influence of dextrans on cardiac preservation in an extracorporeal rat heart model. Eur-Surg-Res 1985; 27: 406-10.
10. 10. Süzer Ö, Kaynar M, Aydinli Ö, Özüner Z. Role of colloid enriched St. Thomas cardioplegic solution in ischemia-reperfusion injury in isolated perfused rat hearts. 5th International Congress of Cardiac, Thoracic and Vascular Anesthesia. Istanbul 1995; 233.
11. 11. Hisatomi K, Hayashida N, Tayama E, Ohashi M, Isomura T, Kosuga K, Oishi K. The effect of additional albumin with optimal concentration on the reperfusion after preservation of isolated rat hearts. Nippon Geka Gakkai Zasshi 1993; 94: 791-5.
12. 12. Hisatomi K, Isomura T, Kosuga K, Yomoda M, Ohishi K. The effect of addition of albumin to cardioplegic and preservation solutions on the isolated heart. J Heart Lung Transpl 1993; 12: 470-5.
13. 13. Süzer Ö, Diri E, Konukoǧlu D, Özüner Z. The role of isocolloidoosmotic synthetic colloid addition to St. Thomas cardioplegic solution for cardioprotection in isolated perfused rat hearts. Pharmacol Res 1997; 36: 9-15.
14. 14. Hisatomi K, Kosuga K, Isomura T, Hirano A, Sato S, Aoyagi S, Oishi K. The preventive effect of additional albumin in crystalloid cardioplegic solution on myocardial reperfusion injury. Nippon Geka Gakkai Zasshi 1993; 94: 1047-50.
15. 15. Hisatomi K, Isomura T, Hayashida N, Sato T, Kosuga K, Aoyagi S. Effect of the addition of albumin to crystalloid cardioplegic solutions on myocardial metabolism in infants undergoing open heart surgery. Surg Today 1996; 26: 395-9.
16. 16. Kates RE, Yee YG, Hill I. Effect of albumin on the electrophysiologic stability of isolated perfused rabbit hearts. J Cardiovasc Pharmacol 1989; 13: 168-72.
17. 17. Van Beek JH, Bouma P, Westerhof N. Coronary resistance increase by nondeffatted albumin in saline perfused rabbit hearts. Am J Physiol 1990; 259: 5Pt 2, H1606-8.
18. 18. Hansen PL, Tschirren B. Clinical experience with 120,000 units of modified fluid gelatine. Dev Biol Standard 1981; 48: 251-6.